Cite
A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
MLA
Arjan Blokland, et al. “A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury.” Current Neuropharmacology, vol. 18, Feb. 2020, pp. 188–201. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....12f1d024342a0ed6cc1c4d96195813ca&authtype=sso&custid=ns315887.
APA
Arjan Blokland, Rudy Schreiber, & Romain Hollands. (2020). A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury. Current Neuropharmacology, 18, 188–201.
Chicago
Arjan Blokland, Rudy Schreiber, and Romain Hollands. 2020. “A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury.” Current Neuropharmacology 18 (February): 188–201. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....12f1d024342a0ed6cc1c4d96195813ca&authtype=sso&custid=ns315887.